Objective: To assess the prognostic value of low-dose 64-slice coronary CT angiography (CCTA) using prospective electrocardiogram (ECG) triggering in a patient population with known or suspected coronary artery disease (CAD).
INTRODUCTION
The advent of multislice coronary computed tomography angiography (CCTA) has provided clinicians with a promising tool for the noninvasive assessment of coronary artery disease (CAD). While the excellent diagnostic accuracy 1 and prognostic performance 2-8 of CCTA have been established, radiation dose exposure has remained an intensely discussed issue and may have in part prevented the widespread use of CCTA in daily clinical routine so far. Early studies with conventional spiral CCTA have reported radiation dose exposures over 20mSv 9 and the introduction of electrocardiographic (ECG) tube current modulation has reduced radiation exposure below 9mSv. 10 The recently introduced scanning protocol using prospective ECG triggering, 11, 12 however, represents a breakthrough with regard to radiation dose reduction in CCTA. In fact, studies using prospectively ECG triggered CCTA have reported radiation doses around 2mSv 11 and below, 13 which proved substantially lower than those obtained from diagnostic invasive coronary angiography (CA) in the first head-to-head comparison. 14 On top of feasibility, 11, 12 accuracy of prospectively triggered CCTA has been reported. 15 However, its prognostic value in an outpatient clinical setting has not yet been established.
Therefore, we sought to assess the prognostic performance of 64-slice CCTA at very low radiation dose exposures using prospective ECG triggering.
METHODS

Study protocol and patient selection
This is an observational, retrospective, non-blinded, single-centre follow-up study.
We enrolled consecutive patients who underwent a low-dose CCTA (using prospective ECG triggering) for evaluation of suspected or known CAD in the absence of any of the commonly accepted exclusion criteria applied to full-dose spiral CCTA. 16 Thus, none of these patients had irregular heartbeat, known allergy to iodinated contrast agent, contraindications for beta-blocking drugs, renal insufficiency (serum creatinin > 150µmol/l), inability to follow breath hold commands or failure to reach a target heart rate (HR) below 65bpm prior to scanning despite intravenous administration of metoprolol. were classified as non-evaluative. If a coronary artery segment was non-evaluative, the segment was scored similarly to the most proximal segment which was evaluable.
2 Thus, all segments were scored in all patients, irrespective of image quality.
Non-obstructive coronary lesions were defined as plaques of an area of equal to or greater than 1mm 2 in orthogonal reconstructions within and/or adjacent to the vessel lumen, not belonging to surrounding tissue. An obstructive lesion was defined as a stenosis with a visual luminal diameter narrowing of equal or greater than 50%.
Effective radiation dose estimation
Values for the effective radiation dose for CCTA were estimated as the product of the dose-length product (DLP) multiplied by a conversion coefficient for the chest.
Among the various factors suggested by the European Working Group for Guidelines on Quality Criteria in Computed Tomography 9 we chose 0.014mSv/mGycm as suggested and used in several large multicenter studies on CCTA radiation dose 9, 20 to ensure comparability of the latter with our results.
Statistical analysis
We used SPSS 17. A two-tailed p-value of < 0.05 was considered statistically significant.
RESULTS
Patient population
Low-dose CCTA with prospective ECG-triggering was performed in 434 patients who were enrolled in the present outcome study. Twenty-nine patients (6.7%) were lost to follow-up due to invalid contact information (n = 18), refusal to provide follow-up data (n = 1), or migration to a foreign country (n = 10).
Thirty-eight patients that underwent early revascularization (i.e. within 6 weeks after CCTA was performed) were excluded. Thus, final outcome analysis was performed in 367 patients. Baseline characteristics are provided in Table 1 . Normal coronary arteries were documented in 171 patients (47%). Nonobstructive coronary lesions were found in 66 (18%), while obstructive lesions were diagnosed in 130 patients (35%).
Effective radiation dose estimation
Mean DLP for CCTA was 126±43mGycm, resulting in a mean effective radiation dose exposure of 1.8±0.6mSv (range: 0.8 -3.8mSv). 
Follow-up results
During
CCTA predictors of events
The results of univariate Cox regression analysis for clinical characteristics, patients' symptoms, cardiovascular risk factors, and CCTA findings are given in Table 2 . The presence of an atherosclerosis as evidenced by any non-obstructive or obstructive lesion was a strong predictor of MACE (hazard ratio = 74.3, p < 0.001). The presence of non-obstructive lesions was a moderate but significant predictor of MACE (hazard ratio = 7.1, p = 0.04). Conversely, patients with obstructive CAD ( Figure 5 ) were at substantially higher risk for MACE on follow-up (hazard ratio 58.6, p = 0.002). The results of multivariate Cox regression analysis corrected for baseline characteristics are given in Table 3 . 
DISCUSSION
The present data demonstrate the excellent prognostic value of prospectively ECG triggered CCTA with a mean effective radiation dose below 2mSv. Absence of atherosclerotic findings in CCTA was an excellent predictor of event-free survival.
Similarly, patients with exclusively non-obstructive lesions had only a slightly reduced event-free survival. By contrast, patients with obstructive lesions had a massive reduction in event-free survival. Furthermore, the extent of obstructive coronary artery disease (i.e. the amount of segments with obstructive lesions) correlated with an adverse cardiac outcome. First-year event rate was 0% for patients without any evidence of atherosclerosis, 3% for patients with non-obstructive lesions, and 26%
for patients with obstructive lesions.
These results are consistent with previous studies reporting up to 40% first year event rates in patients with obstructive CAD. 2-5 The latter studies, however, used spiral CT techniques which are associated with relatively high effective radiation dose exposure to the patients ranging between 8 and 25mSv per scan. By contrast, the effective radiation dose in the present study averaged 1.8±0.6mSv as we used prospective ECG triggering to obtain low-dose CCTA. As radiation safety issues have evoked a vivid discussion on the risk to benefit ratio of CCTA, 21 reduction of radiation dose is essential. This is particularly true for patient populations commonly referred for CCTA as their cardiac event risk is typically low. Furthermore, in such a population the bars seem to be very high to justify the risk of any diagnostic or interventional procedure, as further improvement of prognosis may be difficult to achieve. Therefore, the massive reduction in effective radiation dose by introduction of prospective ECG triggering is important, as it contributes to shift the risk to benefit ratio towards the favourable side of the balance.
After demonstrating the feasibility 11, 12 and diagnostic accuracy 15 and its confirmation in a growing body of literature from many different centres, 22-25 the present study is the first to establish the prognostic performance of low-dose CCTA.
This refinement, merely the successful reduction of radiation dose exposure by an order of magnitude from introduction of spiral CCTA with over 20mSv 9 to prospective triggered CCTA with 2mSv 11, 13 or even scanning in the submillisievert range 26 has allowed CCTA to rapidly evolve from a premature technique to a reliable and valuable clinical tool in daily routine.
Indeed, repeat CCTA scanning for sensing the transition of atherosclerosis into clinically and prognostically relevant CAD or for the monitoring of CAD treatment may no longer be considered prohibitive for radiation concerns.
Limitations
It may be perceived as a potential limitation of the present study that despite the above mentioned improvements in CCTA technique, there is still a small percentage of patients with non-interpretable coronary segments. 12 Latest generation scanners 27, 28 may contribute to further decreasing non-interpretable studies.
Furthermore, it may be perceived as a limitation that coronary interventions were included as events in the present study. In fact, all previous studies assessing the predictive value of spiral CCTA for MACE have included these endpoints. In order to ensure meaningful comparability of our results with prospectively triggered CCTA versus spiral CCTA we followed the design of these previous studies including all revascularization procedures during the entire follow-up period. However, the fact that we have -in contrast to previous studies -excluded all patients revascularized within the first 6 weeks constitutes a strength of the present study, as this period ensures that all procedures triggered by CCTA itself had been excluded from outcome analysis. 
Figure 1
Tertile analysis relating the amount of coronary plaque burden (i.e. the amount of coronary lesions) to the incidence of major adverse cardiac events (MACE). 
